Lars A. Ormandy

2.7k total citations · 3 hit papers
10 papers, 2.3k citations indexed

About

Lars A. Ormandy is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lars A. Ormandy has authored 10 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Lars A. Ormandy's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (3 papers). Lars A. Ormandy is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (3 papers). Lars A. Ormandy collaborates with scholars based in Germany, United States and France. Lars A. Ormandy's co-authors include Michael P. Manns, Tim F. Greten, Firouzeh Korangy, Heiner Wedemeyer, Bastian Hoechst, Frank Lehner, Tina Hillemann, Christine Krüger, Matthias Ballmaier and Jaba Gamrekelashvili and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Hepatology.

In The Last Decade

Lars A. Ormandy

10 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells

2008 653 citations Bastian Hoechst, Lars A. Ormandy et al. Gastroenterology profile →
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor #

2009 529 citations Bastian Hoechst, Lars A. Ormandy et al. Hepatology profile →
Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma

2005 527 citations Lars A. Ormandy, Tina Hillemann et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars A. Ormandy Germany	9	1.8k	1.2k	334	329	214	10	2.3k
Bastian Hoechst Germany	5	1.3k 0.7×	714 0.6×	162 0.5×	233 0.7×	125 0.6×	5	1.6k
Thomas Jamieson United Kingdom	12	541 0.3×	611 0.5×	284 0.9×	526 1.6×	150 0.7×	25	1.5k
Kenji Shibuta Japan	20	499 0.3×	703 0.6×	109 0.3×	573 1.7×	84 0.4×	41	1.4k
Tong Ding China	11	515 0.3×	386 0.3×	157 0.5×	283 0.9×	85 0.4×	17	943
Baiyong Li China	21	691 0.4×	649 0.6×	61 0.2×	524 1.6×	85 0.4×	66	1.5k
Geralyn M. Meny United States	8	995 0.5×	892 0.8×	43 0.1×	578 1.8×	49 0.2×	19	1.7k
Jingwei Sun China	11	753 0.4×	717 0.6×	58 0.2×	438 1.3×	39 0.2×	22	1.3k
Hiroki Hashida Japan	16	404 0.2×	1.0k 0.9×	74 0.2×	768 2.3×	64 0.3×	58	1.8k
Falguni Parikh India	13	425 0.2×	747 0.6×	47 0.1×	474 1.4×	75 0.4×	50	1.3k
P Ardouin France	13	341 0.2×	277 0.2×	107 0.3×	268 0.8×	131 0.6×	19	799

Countries citing papers authored by Lars A. Ormandy

Since Specialization

Citations

This map shows the geographic impact of Lars A. Ormandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars A. Ormandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars A. Ormandy more than expected).

Fields of papers citing papers by Lars A. Ormandy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars A. Ormandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars A. Ormandy. The network helps show where Lars A. Ormandy may publish in the future.

Co-authorship network of co-authors of Lars A. Ormandy

This figure shows the co-authorship network connecting the top 25 collaborators of Lars A. Ormandy. A scholar is included among the top collaborators of Lars A. Ormandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars A. Ormandy. Lars A. Ormandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Gamrekelashvili, Jaba, Lars A. Ormandy, Markus M. Heimesaat, et al.. (2012). Primary sterile necrotic cells fail to cross-prime CD8⁺T cells. OncoImmunology. 1(7). 1017–1026. 31 indexed citations

2.

Zhao, Fei, Bastian Hoechst, Jaba Gamrekelashvili, et al.. (2012). Human CCR4+CCR6+Th17 Cells Suppress Autologous CD8+ T Cell Responses. The Journal of Immunology. 188(12). 6055–6062. 46 indexed citations

3.

Greten, Tim F., Alejandro Forner, Firouzeh Korangy, et al.. (2010). A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma. BMC Cancer. 10(1). 209–209. 174 indexed citations

4.

Greten, Tim F., et al.. (2010). Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC. Journal of Immunotherapy. 33(2). 211–218. 105 indexed citations

5.

Greten, Tim F., Alejandro Forner, Firouzeh Korangy, et al.. (2010). 215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 52. S92–S92. 3 indexed citations

6.

Hoechst, Bastian, Lars A. Ormandy, Jaba Gamrekelashvili, et al.. (2009). Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor #. Hepatology. 50(3). 799–807. 529 indexed citations breakdown →

7.

Hoechst, Bastian, Lars A. Ormandy, Matthias Ballmaier, et al.. (2008). A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells. Gastroenterology. 135(1). 234–243. 653 indexed citations breakdown →

8.

Ormandy, Lars A.. (2006). Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World Journal of Gastroenterology. 12(20). 3275–3275. 83 indexed citations

9.

Ormandy, Lars A., Tina Hillemann, Heiner Wedemeyer, et al.. (2005). Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma. Cancer Research. 65(6). 2457–2464. 527 indexed citations breakdown →

10.

Korangy, Firouzeh, Lars A. Ormandy, Jörg S. Bleck, et al.. (2004). Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular Carcinoma. Clinical Cancer Research. 10(13). 4332–4341. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact